Eton Pharmaceuticals Inc [ETON] stock prices are up 2.66% to $16.99 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The ETON shares have gain 7.40% over the last week, with a monthly amount glided 7.19%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Eton Pharmaceuticals Inc [NASDAQ: ETON] stock has seen the most recent analyst activity on January 23, 2025, when H.C. Wainwright reiterated its Buy rating and also boosted its price target to $33 from $17. Previously, B. Riley Securities started tracking the stock with Buy rating on January 10, 2025, and set its price target to $21. On January 06, 2025, H.C. Wainwright reiterated its Buy rating and revised its price target to $17 on the stock. Craig Hallum initiated its recommendation with a Buy and recommended $8 as its price target on May 06, 2024. In a note dated January 04, 2021, H.C. Wainwright reiterated a Buy rating on this stock and revised its target price from $20 to $15.
The stock price of Eton Pharmaceuticals Inc [ETON] has been fluctuating between $11.09 and $23.00 over the past year. Currently, Wall Street analysts expect the stock to reach $25 within the next 12 months. Eton Pharmaceuticals Inc [NASDAQ: ETON] shares were valued at $16.99 at the most recent close of the market. An investor can expect a potential return of 47.15% based on the average ETON price forecast.
Analyzing the ETON fundamentals
The Eton Pharmaceuticals Inc [NASDAQ:ETON] reported sales of 70.32M for trailing twelve months, representing a surge of 117.54%. Gross Profit Margin for this corporation currently stands at 0.51% with Operating Profit Margin at -0.04%, Pretax Profit Margin comes in at -0.09%, and Net Profit Margin reading is -0.1%. To continue investigating profitability, this company’s Return on Assets is posted at -0.06, Equity is -0.28 and Total Capital is -0.04. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.14.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 16.60 points at the first support level, and at 16.21 for the second support level. However, for the 1st resistance point, the stock is sitting at 17.34, and for the 2nd resistance point, it is at 17.69.
Ratios To Look Out For
It’s worth pointing out that Eton Pharmaceuticals Inc [NASDAQ:ETON]’s Current Ratio is 1.63. Also, the Quick Ratio is 1.25, while the Cash Ratio stands at 0.84. Considering the valuation of this stock, the price to sales ratio is 6.48, the price to book ratio is 19.70.
Transactions by insiders
Recent insider trading involved Gruber James R., Officer, that happened on Dec 12 ’25 when 5450.0 shares were purchased. Officer, BRYNJELSEN SEAN completed a deal on Dec 12 ’25 to buy 8035.0 shares. Meanwhile, Officer Erdogan-Trinkaus Ipek bought 99.0 shares on Dec 12 ’25.
